Management van leveradenomen gedurende de zwangerschap.
- Registration Number
- NL-OMON27872
- Lead Sponsor
- Erasmus University Medical Center Rotterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Study groep:
1. Properly Dutch speaking, pregnant patients;
Exclusion Criteria
Dementia or impaired mental function that would counter the understanding of giving informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the incidence of hepatocellular adenoma growth during pregnancy.
- Secondary Outcome Measures
Name Time Method 1. To investigate in which trimester of pregnancy growth of hepatocellular adenoma (HCA) occurs;<br /><br>2. To investigate the degree of growth of HCA during pregnancy;<br /><br>3. To investigate whether there is regression of HCA postpartum;<br /><br>4. To investigate the HCA-related interventions during pregnancy;<br /><br>5. To investigate the incidence of bleeding of HCA during pregnancy;<br /><br>6. To investigate liver-related clinical signs during pregnancy;<br /><br>7. To investigate elevated liver enzymes during pregnancy;<br /><br>8. To evaluate the quality of life of pregnant patients with HCA;<br /><br>9. To investigate whether there is a difference between quality of life of pregnant patients with HCA and pregnant patients with other comorbidity that have an indication for pregnancy care at the obstetrician in secondary care and healthy pregnant patients.